United States of America
Dr. Mathieu Gaudin has been trained as a Chemist since his Chemical Engineering degree. During his Ph.D. at Paris Descartes University (France), he developed untargeted and semi-targeted mass spectrometry-based approaches for lipidomic characterization of brain tissue samples by liquid chromatography mass spectrometry to understand better the physiopathology of Alzheimer’s disease.
he contributed to the drug distribution strategy and managed the Mass Spectrometry Imaging facility for four years to support drug discovery and development programs. He was also study responsible in pharmacokinetics and metabolism and involved in the corporate program stimulating participative innovation.